智通财经APP讯,亚太药业(002370.SZ)发布公告,近日,公司收到国家药品监督管理局下发的药品注册受理通知书,塞来昔布胶囊是非甾体类抗炎药,用于缓解骨关节炎、成人类风湿关节炎、强直性脊柱炎的症状和体征,治疗成人急性疼痛。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.